Le Lézard
Classified in: Health, Science and technology
Subjects: Contract/Agreement, Product/Service

Atomwise Announces Largest China-US Collaboration for AI Drug Discovery


Atomwise Inc. ("Atomwise"), the leader in artificial intelligence (AI) for drug discovery, today announced a collaboration with Hansoh Pharmaceutical Group Company Limited ("Hansoh Pharma"), a leading biopharmaceutical company in China, to design and discover potential drug candidates for up to eleven undisclosed target proteins in multiple therapeutic areas.

"There is exciting science happening throughout Asia, and enormous potential for leadership in innovative drug discovery," said Dr. Abraham Heifets, CEO of Atomwise. "I am delighted to announce that Hansoh Pharma is our first partner in Asia. Hansoh Pharma is committed to innovation and shares our mission for global impact on patient health," he added.

Scientific teams from Atomwise and Hansoh Pharma will collaborate closely on the programs. The combination of Atomwise's AI technology and medicinal chemistry and protein structure expertise, and Hansoh Pharma's fully integrated research and development, manufacturing and commercial capabilities has the potential to dramatically increase success and compress timelines for drug discovery and clinical development.

Under the terms of the collaboration, Atomwise will receive undisclosed technology access fees, option exercise fees, royalties, and income based on sublicensing or sale of assets created under the collaboration. Based on historical average revenues for small molecule drugs, the total potential value of the deal to Atomwise with success in all projects could reach US$1.5 billion.

About Atomwise
Atomwise Inc. invented the first deep learning AI technology for structure-based small molecule drug discovery. Created in 2012, today Atomwise performs hundreds of projects per year in partnership with some of the world's largest pharmaceutical and agrochemical companies, as well as over a hundred universities and hospitals in 19 countries. Atomwise has raised over $50 million from leading venture capital firms to support the development and application of its AI technology. Learn more at atomwise.com or follow @AtomwiseInc.


These press releases may also interest you

at 12:05
HTEC, a global digital consulting, software engineering, and product development company, is announcing a strategic collaboration with G2 Risk Solutions (G2RS), the preeminent provider of end-to-end bankruptcy technology solutions. Under the...

at 12:05
Enterprise Connect, the leading conference and exhibition for enterprise communications and customer experience (CX), brought IT decision-makers together to improve business communications and CX. Attendees explored industry trends and technologies...

at 12:05
Terragia Biofuel, a technology startup aiming to drive the next generation of biofuels, today announced it has raised a $6 million seed round led by Engine Ventures and Energy Impact Partners (EIP). The company will use the capital to commercialize...

at 12:00
Helika, a leading global infrastructure provider for traditional and Web3 gaming, launches Helika Accelerate, an accelerator program dedicated to supporting top gaming studios around the globe to develop Web3 games and to sustain growth in users and...

at 12:00
The Russell Innovation Center for Entrepreneurs (RICE), the largest center in the world dedicated to growing, scaling, and developing Black entrepreneurs proudly announces the strategic enhancement of its leadership team with two distinguished...

at 12:00
Today, the Linux Foundation announced its intent to form Valkey, an open source alternative to the Redis in-memory, NoSQL data store. Project contributors quickly gathered maintainer, community, and corporate support to regroup in response to the...



News published on and distributed by: